These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25264683)

  • 1. The value of mainstreaming human rights into health impact assessment.
    MacNaughton G; Forman L
    Int J Environ Res Public Health; 2014 Sep; 11(10):10076-90. PubMed ID: 25264683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health impact assessment, human rights and global public policy: a critical appraisal.
    Scott-Samuel A; O'Keefe E
    Bull World Health Organ; 2007 Mar; 85(3):212-7. PubMed ID: 17486213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impacts.
    Gleeson D; Lexchin J; Labonté R; Townsend B; Gagnon MA; Kohler J; Forman L; Shadlen KC
    Global Health; 2019 Nov; 15(Suppl 1):78. PubMed ID: 31775767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is health impact assessment useful in the context of trade negotiations? A case study of the Trans Pacific Partnership Agreement.
    Hirono K; Haigh F; Gleeson D; Harris P; Thow AM; Friel S
    BMJ Open; 2016 Apr; 6(4):e010339. PubMed ID: 27044579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addressing legal and political barriers to global pharmaceutical access: options for remedying the impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the imposition of TRIPS-plus standards.
    Cohen-Kohler JC; Forman L; Lipkus N
    Health Econ Policy Law; 2008 Jul; 3(Pt 3):229-56. PubMed ID: 18634618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public health-oriented intellectual property and trade policies in Africa and the regional mechanism under Trade-Related Aspects of Intellectual Property Rights amendment.
    Adekola TA
    Public Health; 2019 Aug; 173():1-4. PubMed ID: 31203136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could international compulsory licensing reconcile tiered pricing of pharmaceuticals with the right to health?
    Ooms G; Forman L; Williams OD; Hill PS
    BMC Int Health Hum Rights; 2014 Dec; 14():37. PubMed ID: 25518744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evolution of the international intellectual property rights system: patent protection for the pharmaceutical industry and access to medicines].
    Chaves GC; Oliveira MA; Hasenclever L; de Melo LM
    Cad Saude Publica; 2007 Feb; 23(2):257-67. PubMed ID: 17221075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing the legal provisions for HIA in Slovakia: an exploration of practitioner perspectives.
    O'Mullane M
    Health Policy; 2014 Jul; 117(1):112-9. PubMed ID: 24931901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Health Impact Assessments: A Synthesis of Data From Five Impact Evaluation Reports.
    Dannenberg AL
    Prev Chronic Dis; 2016 Jun; 13():E84. PubMed ID: 27362932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Process, Practice and Progress: A Case Study of the Health Impact Assessment (HIA) of Brexit in Wales.
    Green L; Ashton K; Edmonds N; Azam S
    Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32932632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A strategy for institutionalisation of health impact assessment in Andalusia (Spain)].
    Vela-Ríos J; Rodríguez-Rasero FJ; Moya-Ruano LA; Candau-Bejarano A; Ruiz-Fernández J
    Gac Sanit; 2016; 30(1):81-4. PubMed ID: 26515249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Framework for Participatory Quantitative Health Impact Assessment in Low- and Middle-Income Countries.
    Thondoo M; De Vries DH; Rojas-Rueda D; Ramkalam YD; Verlinghieri E; Gupta J; Nieuwenhuijsen MJ
    Int J Environ Res Public Health; 2020 Oct; 17(20):. PubMed ID: 33096783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementing Health Impact Assessment Programs in State Health Agencies: Lessons Learned From Pilot Programs, 2009-2011.
    Goff N; Wyss K; Wendel A; Jarris P
    J Public Health Manag Pract; 2016; 22(6):E8-E13. PubMed ID: 27682735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health equity impact assessment.
    Povall SL; Haigh FA; Abrahams D; Scott-Samuel A
    Health Promot Int; 2014 Dec; 29(4):621-33. PubMed ID: 23449601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health impact assessment as an accountability mechanism for the International Monetary Fund: the case of sub-Saharan Africa.
    O'Keefe E; Scott-Samuel A
    Int J Health Serv; 2010; 40(2):339-45. PubMed ID: 20440978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medications.
    Baxi SM; Beall R; Yang J; Mackey TK
    Global Health; 2019 Sep; 15(1):57. PubMed ID: 31533850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are drug companies living up to their human rights responsibilities? The perspective of the former United Nations Special Rapporteur (2002-2008).
    Hunt P; Khosla R
    PLoS Med; 2010 Sep; 7(9):e1000330. PubMed ID: 20927413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health Impact Assessment of an oil drilling project in California.
    McCallum LC; Souweine K; McDaniel M; Koppe B; McFarland C; Butler K; Ollson CA
    Int J Occup Med Environ Health; 2016; 29(2):229-53. PubMed ID: 26670354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A New Framework for Monitoring and Evaluating Health Impact Assessment: Capitalising on a French Case Study with the Literature in Evaluation.
    Jabot F; Romagon J; Dardier G
    Int J Environ Res Public Health; 2024 Sep; 21(9):. PubMed ID: 39338123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.